[囊性纤维化-ETI和2型N-of-1试验:下一步]
Patrick Lebecque1, Olivia Bauraind2, Matthieu Thimmesch1
1Service de Pneumologie pédiatrique & Centre Liégeois de Référence pour la Mucoviscidose, CHC MontLégia, Liège, Belgique.
Revue medicale de Liege
|October 13, 2023
概括
N-of-1试验显示,超过一半的囊性纤维化患者对三重疗法 (ETI) 有反应. 这种具有成本效益的方法提供了一种务实的方法来评估那些无法获得先进预测工具的人的治疗疗效.
科学领域:
- 基于证据的医学是基于证据的医学.
- 罕见的和异质的条件.
- 临床试验的设计
背景情况:
- N-of-1试验对于罕见和异质的疾病有价值.
- 有效的三重疗法 (ETI) 可用于患有F508del突变的囊性纤维化 (CF) 患者.
- 许多CF患者携带罕见突变,这些突变不受当前ETI资格标准的覆盖.
研究的目的:
- 评估N-of-1试验对预测罕见突变CF患者ETI疗效的有用性.
- 探索一种务实的,具有成本效益的方法,在没有复杂的预测工具的情况下评估个体治疗反应.
主要方法:
- 描述一种2型N-of-1试验设计.
- 使用简单,可靠的临床和准临床结果进行疗效评估.
- 进行4-6周的ETI试验,以评估患者的反应.
主要成果:
- 超过一半的研究患者对ETI表现出临床上有意义的反应.
- N-of-1试验方法证明了预测个体ETI反应的可行性和潜力.
- 这种方法绕过了昂贵和难以获得的预测工具的需求.
结论:
- N-of-1试验提供了一种务实且具有成本效益的方法,用于评估罕见突变的CF患者的ETI疗效.
- 这种方法为个性化CF治疗决策提供了宝贵的见解.
- 需要进一步讨论这种N-of-1试验方法的价值和局限性.
相关概念视频
Clinical Trials: Overview
3.0K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.0K
Cystic Fibrosis: Management
173
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
173
Cystic Fibrosis: Pathogenesis
256
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
256
Clinical Trials
6.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.8K
Crossover Experiments
2.9K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
2.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
133
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
133


